NTV Asset Management LLC Sells 2,404 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

NTV Asset Management LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 52,996 shares of the financial services provider’s stock after selling 2,404 shares during the quarter. iShares Biotechnology ETF makes up about 1.2% of NTV Asset Management LLC’s investment portfolio, making the stock its 17th largest holding. NTV Asset Management LLC owned approximately 0.10% of iShares Biotechnology ETF worth $7,199,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Avidian Wealth Solutions LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $302,000. TCG Advisory Services LLC bought a new position in iShares Biotechnology ETF in the fourth quarter worth $268,000. Axxcess Wealth Management LLC lifted its position in iShares Biotechnology ETF by 55.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 6,486 shares of the financial services provider’s stock valued at $881,000 after buying an additional 2,310 shares during the period. First Horizon Advisors Inc. boosted its holdings in shares of iShares Biotechnology ETF by 5.5% during the 4th quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock valued at $298,000 after buying an additional 115 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $204,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of iShares Biotechnology ETF stock traded up $2.31 during trading on Friday, hitting $132.96. The company’s stock had a trading volume of 1,804,184 shares, compared to its average volume of 1,700,513. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The company has a fifty day simple moving average of $133.61 and a two-hundred day simple moving average of $129.99.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.38%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.